Drawing for LIPHA

USPTO serial 75844028

LIPHA

Reviewed by CopyMark Law Group

Reg. 2531237Status 710
Filing date
Status date
Registration date
Jan 22, 2002
Examiner
CHICOSKI, JENNIFER D
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with LIPHA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brooks R. Bruneau

BROOKS R BRUNEAU MATHEWS, COLLINS, SHEPHERD & GOULD PA100 THANET CIR STE 306PRINCETON, NJ 08540-3662UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Full line of industrial chemical preparations used in producing pharmaceuticals, medical preparations, dietetic and dermo-cosmetic preparations, foods and non-alcoholic drinks, and toiletry productsSECTION 8 - CANCELLED—
003House mark for a full line of cosmetic productsSECTION 8 - CANCELLED—
005Pharmaceutical products for the therapeutic management and treatment of asthma, chronic obstructive pulmonary disease, bronchitis, and other respiratory ailments; pharmaceutical products for the relief of bronchial spasms, for the management of hypertension, for the treatment of moderate to moderately severe pain, for the treatment of angina pectoris and acute myocardial infarction, for acute or long term use in the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis, for the management of anxiety disorder, for the short term relief of symptoms of anxiety, for the short term treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes, and pharmaceutical preparations for treatment of the central and peripheral nervous systemSECTION 8 - CANCELLED—
042Chemical, pharmaceutical, dietetic, dermo-cosmetic and biotechnology analysis and research; design and testing for new product development; diagnostic testing and analysis, namely, medical research and industrial uses; licensing of patents, trademarks and intellectual property; scientific research in the fields of chemistry, biotechnology and pharmacology; legal services, including patent and trademark registration, maintenance and litigation; intellectual property consultation; material testing; product safety testing; reviewing standards and practices to assure compliance with product safety and environmental laws and regulations; hospital, medical, clinical and health care servicesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2008C8..CANCELLED SEC. 8 (6-YR)—
Apr 12, 2007CFITCASE FILE IN TICRS—
Jan 22, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 30, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 10, 2001NPUBNOTICE OF PUBLICATION—
Apr 8, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2001CNEAEXAMINER'S AMENDMENT MAILED—
Feb 7, 2001DOCKASSIGNED TO EXAMINER—
Oct 4, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 20001.BDSec. 1(B) CLAIM DELETED—
Apr 4, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance